CUSIP 92332V107COMVTYXUSDQ4 2025
57 filings · latest Mar 5, 2026
Largest reported positions · latest quarter
| # | Fund | Shares | Value |
|---|---|---|---|
| 1 | Affinity Asset Advisors, LLC | 6.48M | $58.56M |
| 2 | Morgan Stanley | 4.29M | $38.77M |
| 3 | Vanguard Group Inc | 3.94M | $35.61M |
| 4 | Blackrock, Inc. | 3.14M | $28.38M |
| 5 | Tang Capital Management LLC | 2.81M | $25.41M |
| 6 | Baker Bros. Advisors LP | 2.35M | $21.21M |
| 7 | Braidwell LP | 1.92M | $17.34M |
| 8 | D. E. Shaw & Co., Inc. | 1.67M | $15.04M |
| 9 | Mpm Bioimpact LLC |
| 4 | Feb 5, 2026 | Morgan Stanley | 13G | 6.0% | 4.29M | SEC |
| 5 | Jan 29, 2026 | Affinity Asset Advisors, LLC | 13G/A | 9.0% | 6.47M | SEC |
| 6 | Jan 9, 2026 | Raju Mohan | 13D/A | 6.0% | — | SEC |
| 7 | Jan 9, 2026 | Subramaniam Somu | 13D/A | 5.8% | — | SEC |
| 8 | Nov 26, 2025 | Raju Mohan | 13D | 6.0% | — | SEC |
| 9 | Nov 14, 2025 | Point72 Asset Management, L.P. | 13G/A | 4.5% | 3.21M | SEC |
| 10 | Oct 31, 2025 | The Vanguard Group | 13G | 5.3% | 3.77M | SEC |
See the full Schedule 13D/13G history for Ventyx Biosciences Inc.
Unlock full history| 1.64M |
| $14.80M |
| 10 | Citadel Advisors LLC | 1.56M | $14.12M |